Report overview
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart.
This report aims to provide a comprehensive presentation of the global market for Cardiac Biomarkers Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiac Biomarkers Testing. This report contains market size and forecasts of Cardiac Biomarkers Testing in global, including the following market information:
Global Cardiac Biomarkers Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Cardiac Biomarkers Testing market was valued at US$ 7339.2 million in 2022 and is projected to reach US$ 11200 million by 2029, at a CAGR of 6.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cardiac biomarkers are the substances released into the blood stream from the damaged muscle of the heart. These biomarkers are used to diagnose heart functioning, risk stratifications, and cardiac diseases in patients. Biomarker is a quantifiable and measurable biological parameter that includes an enzyme, hormones, and proteins, all associated with heart function, failure, or damage.
We surveyed the Cardiac Biomarkers Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Biomarkers Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Cardiac Biomarkers Testing Market Segment Percentages, by Type, 2022 (%)
Myocardial Muscle Creatine Kinase (CK-MB)
Troponins (T and I)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia-modified Albumin (IMA)
Others
Global Cardiac Biomarkers Testing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Cardiac Biomarkers Testing Market Segment Percentages, by Application, 2022 (%)
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Global Cardiac Biomarkers Testing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Cardiac Biomarkers Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Biomarkers Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cardiac Biomarkers Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Becton, Dickinson and Company
BioMerieux
Bio-Rad Laboratories, Inc.
Danaher Corporation
ROCHE
Siemens AG
Thermo Fisher Scientific, Inc.
PerkinElmer Inc.
Tosoh Corporation
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cardiac Biomarkers Testing, market overview.
Chapter 2: Global Cardiac Biomarkers Testing market size in revenue.
Chapter 3: Detailed analysis of Cardiac Biomarkers Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cardiac Biomarkers Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
